Concepedia
Statistics
Publications
16
Citations
2.1K
H-Index
15
Active since
2018
Affiliations
Queen Mary University of London(Current)
University College London
Hospital Universitario Reina Sofía
Hospital Universitario Virgen del Rocío
Nottingham University Hospitals NHS Trust
Aaron Prendergast is an author at Queen Mary University of London specializing in medicine, oncology, and pharmacology.
Publications per year
2018–2023
Clinical efficacy and biomarker analysis of neoadjuvant atezolizumab in operable urothelial carcinoma in the ABACUS trial
Thomas Powles, Mark Kockx, Alejo Rodríguez‐Vida et al. · Nature Medicine · 2019 · 571 citations · Full text
Medicine, Oncology, Urology +13
Capivasertib Plus Paclitaxel Versus Placebo Plus Paclitaxel As First-Line Therapy for Metastatic Triple-Negative Breast Cancer: The PAKT Trial
Peter Schmid, Jacinta Abraham, Stephen Chan et al. · Journal of Clinical Oncology · 2019 · 389 citations · Full text
Medicine, Oncology, Pharmacology +16
Phase I clinical trial repurposing all-trans retinoic acid as a stromal targeting agent for pancreatic cancer
Hemant M. Kocher, Bristi Basu, Fieke E. M. Froeling et al. · Nature Communications · 2020 · 208 citations · Full text
Medicine, Oncology, Pharmacology +17
Final Results of Neoadjuvant Atezolizumab in Cisplatin-ineligible Patients with Muscle-invasive Urothelial Cancer of the Bladder
Bernadett Szabados, Mark Kockx, Zoe J. Assaf et al. · European Urology · 2022 · 190 citations · Full text
Faecal immunochemical tests versus colonoscopy for post-polypectomy surveillance: an accuracy, acceptability and economic study
Wendy Atkin, Amanda J. Cross, Ines Kralj‐Hans et al. · Health Technology Assessment · 2019 · 128 citations · Full text
Medicine, Oncology, Surgery +17
1–5 of 16